Scorpion Therapeutics is a private drug discovery company. It has raised $150 million across 3 recorded rounds; the latest was a $150 million Series C in Jul 2024.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$150.0M
Last round
Later Stage VC (Series C)
Jul 2024
Cap table — not yet on record
Scorpion Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Where does Scorpion Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Scorpion Therapeutics's 3 recorded funding rounds.
